Literature DB >> 15351739

Pancreas developing markers expressed on human mononucleated umbilical cord blood cells.

A Pessina1, B Eletti, C Croera, N Savalli, C Diodovich, L Gribaldo.   

Abstract

Haematopoietic system represents the main source of haematopoietic stem cells and probably of multipotential adult progenitor cells and mesenchimal stem cells at first described as colony forming unit-fibroblast. Whereas there are many studies on the gene expression profile of the different precursors along their haematopoietic differentiation, few data (sometimes conflicting) have been reported about the phenotype of the cells (present in bone marrow and possibly in cord blood) able to differentiate into non-haematopoietic cells. As both postnatal bone marrow and umbilical cord blood contain nestin positive cells able to proliferate and differentiate into the main neural phenotype (neuron, astroglia and oligodendroglia) many authors considered nestin a neuroepithelial precursor marker that seems to be essential also in multipotential progenitor cells of pancreas present both in rat and in human pancreatic islets (called nestin positive islet derived progenitors). Although the importance of nestin in these cells appears to be evident, it remains yet to clarify the number and the sequential expression of the genes coding all the transcription factors essential for beta cells differentiation and therefore the conditions able to induce the expression of many important transcription factors genes such as isl-1, pax-4, pdx-1 and ngn-3. Among them pdx-1 is a gene essential for pancreas development which is able to control ngn-3 in activating the expression of other differentiation factors for endocrine cells. Here, we describe for the first time in human umbilical cord blood cells (UCB) the pattern of expression of a panel of markers (nestin, CK-8, CK-18) and transcription factors (Isl-1, Pdx-1, Pax-4, Ngn-3) considered important for beta cells differentiation. Our data demonstrate that UCB contains a cell population having a phenotype very similar to endocrine cell precursors in transition to beta cells. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351739     DOI: 10.1016/j.bbrc.2004.08.088

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Authors:  Rita Anzalone; Melania Lo Iacono; Tiziana Loria; Antonino Di Stefano; Pantaleo Giannuzzi; Felicia Farina; Giampiero La Rocca
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 2.  Cellular therapies for type 1 diabetes.

Authors:  D D Lee; E Grossman; A S Chong
Journal:  Horm Metab Res       Date:  2008-02       Impact factor: 2.936

3.  The application of umbilical cord blood cells in the treatment of diabetes mellitus.

Authors:  Tomas Koblas; S Mitchell Harman; Frantisek Saudek
Journal:  Rev Diabet Stud       Date:  2006-02-10

Review 4.  Present and future cell therapies for pancreatic beta cell replenishment.

Authors:  Juan Domínguez-Bendala; Camillo Ricordi
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 5.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 6.  Stem cells, a two-edged sword: risks and potentials of regenerative medicine.

Authors:  Anna-Chiara Piscaglia
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 7.  Concise review: mesenchymal stem cells for diabetes.

Authors:  Juan Domínguez-Bendala; Giacomo Lanzoni; Luca Inverardi; Camillo Ricordi
Journal:  Stem Cells Transl Med       Date:  2011-12-07       Impact factor: 6.940

8.  Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.

Authors:  Augusto Pessina; Arianna Bonomi; Valentina Coccè; Gloria Invernici; Stefania Navone; Loredana Cavicchini; Francesca Sisto; Maura Ferrari; Lucia Viganò; Alberta Locatelli; Emilio Ciusani; Graziella Cappelletti; Daniele Cartelli; Caruso Arnaldo; Eugenio Parati; Giovanni Marfia; Roberto Pallini; Maria Laura Falchetti; Giulio Alessandri
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

9.  Cell-based regenerative strategies for treatment of diabetic skin wounds, a comparative study between human umbilical cord blood-mononuclear cells and calves' blood haemodialysate.

Authors:  Hala O El-Mesallamy; Mohamed R Diab; Nadia M Hamdy; Sarah M Dardir
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

10.  Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges.

Authors:  Nagwa El-Badri; Mohamed A Ghoneim
Journal:  J Nucleic Acids       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.